FDA inspection
Medlife Pharmacy and Compounding: FDA inspection ending Jun 15, 2021
FDA inspection 1144689 · No Action Indicated (NAI) · Irvine, CA
Key facts
| Inspection ID | 1144689 |
|---|---|
| Firm | Medlife Pharmacy and Compounding |
| FEI number | 3014332926 |
| Address | 6644 Irvine Center Dr |
| City | Irvine |
| State | CA |
| ZIP | 92618 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Jun 15, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data